We recently published a list of Top 10 Insider Purchases Last Month. In this article, we are going to take a look at where ...

Metsera , Inc. (NASDAQ:MTSR), a pharmaceutical company with a market capitalization of $2.68 billion, has disclosed the approval of 2024 annual cash bonuses for its named executive officers ...

Metsera , Inc. (NASDAQ:MTSR), a pharmaceutical company with a market capitalization of $2.68 billion, has disclosed the approval of 2024 annual cash bonuses for its named executive officers, following ...

The third among the stocks with the highest value of insider purchases in February is a clinical-stage biotechnology company, Metsera. The New York City-based company is developing injectable and ...

Metsera is leaving no fundraising stone unturned as it races to grab a slice of the fast-growing market for obesity drugs. Just nine months after emerging from stealth with a $290 million Series A ...

The deal gives the Swiss pharma access to an experimental amylin-targeting treatment it will test in combination with drugs ...

If any further evidence were needed for the insatiable investor appetite for companies with obesity assets, look no further than New York start-up Metsera. After emerging from stealth with a $290 ...

How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...